A Study to Assess the Absolute Bioavailability of Oral Selumetinib in Healthy Male Volunteers.

NCT02238782 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers Bioavailability Study

Interventions

DRUG: selumetinib 75mg single dose
OTHER: [14C] selumetinib IV solution

Sponsor

AstraZeneca